ZA200208662B - Thrombopoietin receptor modulating peptide. - Google Patents

Thrombopoietin receptor modulating peptide.

Info

Publication number
ZA200208662B
ZA200208662B ZA200208662A ZA200208662A ZA200208662B ZA 200208662 B ZA200208662 B ZA 200208662B ZA 200208662 A ZA200208662 A ZA 200208662A ZA 200208662 A ZA200208662 A ZA 200208662A ZA 200208662 B ZA200208662 B ZA 200208662B
Authority
ZA
South Africa
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
ZA200208662A
Other languages
English (en)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva Farmaceutska Ind
Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Ind, Dionicko Drustvo filed Critical Pliva Farmaceutska Ind
Publication of ZA200208662B publication Critical patent/ZA200208662B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200208662A 2000-04-25 2002-10-25 Thrombopoietin receptor modulating peptide. ZA200208662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (de) 2000-04-25 2000-04-25 Thrombopoietin Rezeptormodulations Peptide

Publications (1)

Publication Number Publication Date
ZA200208662B true ZA200208662B (en) 2003-10-27

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200208662A ZA200208662B (en) 2000-04-25 2002-10-25 Thrombopoietin receptor modulating peptide.

Country Status (24)

Country Link
US (1) US20030181659A1 (de)
EP (2) EP1149906A1 (de)
JP (1) JP2003530867A (de)
KR (1) KR20030009450A (de)
CN (1) CN1426467A (de)
AR (1) AR030278A1 (de)
AU (2) AU2001267366B9 (de)
BG (1) BG107214A (de)
BR (1) BR0110383A (de)
CA (1) CA2407167A1 (de)
CZ (1) CZ20023517A3 (de)
EA (1) EA006423B1 (de)
EE (1) EE200200610A (de)
GE (1) GEP20063763B (de)
HU (1) HUP0300559A3 (de)
IL (1) IL152204A0 (de)
IS (1) IS6582A (de)
MX (1) MXPA02010458A (de)
NO (1) NO20025114L (de)
PL (1) PL358304A1 (de)
SK (1) SK15262002A3 (de)
WO (1) WO2001080873A2 (de)
YU (1) YU79202A (de)
ZA (1) ZA200208662B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1451364A4 (de) * 2001-11-07 2007-08-22 Millennium Pharm Inc Verfahren und zusammensetzungen zur behandlung hämatologischer erkrankungen mit 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 oder 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
MXPA05003057A (es) * 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
CA2509914A1 (en) 2002-12-11 2004-06-24 Ferrosan A/S Gelatine-based materials as swabs
WO2004101600A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Novel poly(ethylene glycol) modified compounds and uses thereof
MXPA05012314A (es) * 2003-05-12 2006-04-18 Affymax Inc Radical separador para peptido modificado con polietilenglicol.
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
CN101001649B (zh) 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
AU2007210643B2 (en) * 2006-01-31 2013-09-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for determination of condition of disseminated intravascular coagulation syndrome
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
JP5824760B2 (ja) * 2011-05-13 2015-12-02 国立大学法人 東京大学 多核化巨核球細胞、及び血小板の製造方法
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
RU2700162C2 (ru) 2013-06-21 2019-09-13 Ферросан Медикал Дивайсиз А/С Расширенная под вакуумом сухая композиция и шприц для ее сохранения
EP3470094B1 (de) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Trockenzusammensetzung mit extrusionsverstärker
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2019215274A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
AU6046696A (en) * 1995-06-07 1996-12-30 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
CA2322200A1 (en) * 1998-02-24 1999-08-26 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
IS6582A (is) 2002-10-14
IL152204A0 (en) 2003-05-29
YU79202A (sh) 2006-01-16
GEP20063763B (en) 2006-03-10
CA2407167A1 (en) 2001-11-01
US20030181659A1 (en) 2003-09-25
KR20030009450A (ko) 2003-01-29
WO2001080873A3 (en) 2002-01-31
EA006423B1 (ru) 2005-12-29
HUP0300559A2 (hu) 2003-06-28
HUP0300559A3 (en) 2005-09-28
AU6736601A (en) 2001-11-07
BG107214A (bg) 2003-11-28
AR030278A1 (es) 2003-08-20
EP1278849A2 (de) 2003-01-29
NO20025114L (no) 2002-12-18
MXPA02010458A (es) 2003-06-06
AU2001267366B9 (en) 2005-07-14
AU2001267366B2 (en) 2005-06-30
SK15262002A3 (sk) 2003-05-02
EP1149906A1 (de) 2001-10-31
CZ20023517A3 (cs) 2003-10-15
EA200201138A1 (ru) 2003-06-26
EE200200610A (et) 2004-08-16
CN1426467A (zh) 2003-06-25
JP2003530867A (ja) 2003-10-21
WO2001080873A2 (en) 2001-11-01
PL358304A1 (en) 2004-08-09
BR0110383A (pt) 2003-01-21
NO20025114D0 (no) 2002-10-24

Similar Documents

Publication Publication Date Title
MXPA03002410A (es) 4-amino-quinazolinas.
ZA200208662B (en) Thrombopoietin receptor modulating peptide.
MXPA03005445A (es) Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
ZA200205479B (en) Novel biarylcarboxamides.
MXPA03002256A (es) Factor viii modificado.
MXPA02011727A (es) Peptidos neuroprotectores.
MXPA03005256A (es) Contenedor para liquidos.
ZA200101012B (en) Pharmaceutical combinations.
MXPA03004885A (es) Base de conexion.
EG23262A (en) Delta -pyrrolines.
HK1055426A1 (en) Indoloquinazolinones.
MXPA03001591A (es) Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
MXPA03004281A (es) Poliamida.
MXPA03001877A (es) 2-guanidin-4-arilquinazolinas.
MXPA03002668A (es) Guanidinas de sulfonilo.
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
MXPA03005714A (es) Sulfamidotienopirimidinas.
MXPA03002411A (es) 4-amino-quinazolinas.
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
MXPA03005494A (es) Benzoilpiridazinas.
HK1061560A1 (en) Triazolo-epothilones.
MXPA03005217A (es) Dispositivos para aplicar un parche.
GB0002612D0 (en) C.m.e
GB0007510D0 (en) D.o.t.t.s
TJ414B (en) Thermoresistor.